Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SYK vs GSK✓SelectedUSD · GSKSYK vs GSK performance historyLatest closeAs of-0.98%11/20
Stock and ETF performance explorer

SYK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.5%
GSK return
+40.7%
Excess return
-15.1%
Maximum drawdown
-32.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-0.1%-0.9%-0.9%
7D+0.1%-5.3%+5.4%+1.8%
30D+4.2%-3.7%+7.8%+5.3%
3M-5.1%-7.3%+2.2%-2.9%
6M-3.0%-4.2%+1.2%-1.7%
YTD-11.0%+0.9%-11.9%-11.3%
1Y-13.1%+7.3%-20.3%-14.8%
3Y+10.4%+52.7%-42.4%-4.6%
All+25.5%+40.7%-15.1%+4.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling